Objective: Hysterectomy, with or without oophorectomy, is associated with increased cardiovascular disease (CVD) risk due, in part, to an adverse CVD risk factor profile. Large artery stiffening, a biomarker of vascular aging, increases the risk for CVD. We determined whether hysterectomy with or without bilateral oophorectomy (BLO) is associated with arterial stiffening in healthy postmenopausal women.
C ardiovascular disease (CVD) is the leading cause of death for women in the United States. 1 The prevalence of CVD increases with advancing age in both women and men, with premenopausal women having a lower prevalence compared with age-matched men until around the time of the menopausal transition, where thereafter, women have an equal or greater prevalence of CVD. 1 This female advan-tage has often been attributed to the protective effects of estrogen during the premenopausal years, which is then lost when ovarian function declines with menopause. Indeed, premature menopause, including hysterectomy with ovarian preservation or with oophorectomy (bilateral or unilateral), has been reported to be a significant predictor of CVD. 2, 3 The CVD risk associated with hysterectomy itself (with intact ovaries) has been attributed to early menopause related to premature ovarian failure from disruption of ovarian blood flow. 2, 4 The increased CVD risk with hysterectomy (regardless of oophorectomy status) has been attributed to an adverse CVD risk factor profile. 3 However, a substudy of the Women's Health Initiative (WHI) placebo-controlled trial of conjugated equine estrogens demonstrated that hysterectomy (including bilateral or unilateral oophorectomy) without history of menopausal hormone therapy (HT) was associated with subclinical coronary artery disease independent of traditional CVD risk factors. 5 Moreover, among women with bilateral oophorectomy (BLO), HT use within 5 years of surgical operation was associated with a lower prevalence of subclinical atherosclerosis. 5 These findings are consistent with the idea that estrogen deficiency associated with hysterectomy is related to the development of CVD. Because hysterectomy is the second most common surgical procedure among women in the United States, a full understanding of the mechanisms behind its link to increased CVD risk is of clinical importance. 6 Large artery stiffening, a biomarker of vascular aging, is a predictor of cardiovascular (CV) events. 7 In most individuals, vascular aging is a gradual process. However, in certain conditions, including menopause, the vascular aging process seems to be accelerated, particularly with estrogen deficiency. Indeed, arterial stiffness is greater in postmenopausal women compared with age-matched premenopausal women and lower in postmenopausal women using HT compared with women not using HT. 8<10 However, whether hysterectomy with or without BLO alters age-associated large artery stiffening in postmenopausal women is unclear. Accordingly, in the present study, we determined whether hysterectomy with or without BLO was associated with large artery stiffening in estrogendeficient postmenopausal women.
METHODS Participants
A total of 103 healthy postmenopausal women (46-80 y of age) who were estrogen deficient (no use of HT for at least 6 mo at study entry) were studied. Postmenopausal women did not have menses for at least 1 year and had follicle-stimulating hormone concentrations greater than 30 IU/L. Forty-five women had a history of either hysterectomy with ovarian preservation (n = 24) or hysterectomy with BLO (n = 21), and 58 women did not have a hysterectomy or BLO. Age at menopause, postmenopause duration, previous HT use, age at menarche, and parity were obtained from medical history and physical examination. The number of years postmenopause was estimated from self-reported age at menopause in women who did not have a hysterectomy or who had a hysterectomy with ovarian preservation and from self-reported date of surgical operation in those who had a hysterectomy with BLO. Women were sedentary or recreationally active (no planned regular exercise 93 d/wk), normotensive, nonsmokers, not taking any CV or lipid-lowering medications, and free of overt chronic diseases as assessed by medical history, physical examination, standard blood chemistries, and hematological evaluation. All women gave their written informed consent to participate. All procedures were reviewed and approved by the University of Colorado at Boulder Human Research Committee and the University of Colorado Denver Colorado Multiple Institutional Review Board.
Study procedures
All measurements were performed at the University of Colorado at Boulder and the University of Colorado Denver Clinical Translational Research Centers after at least a 4-hour fast (12 h for determination of metabolic parameters) and abstinence from caffeine.
Arterial stiffness
Two common indices of arterial stiffness were measured: carotid artery compliance, which is the change in cross-sectional area of a vessel per unit of pressure, and A stiffness index, which provides an index of arterial compliance adjusted for distending pressure. Arterial compliance and A stiffness were determined using high-resolution ultrasound imaging of the carotid artery as previously described. 9, 11 Peripheral arterial blood pressure was measured with a semiautomated device (Dinamap, Johnson & Johnson) over the brachial artery. 11 Carotid images were analyzed for arterial distention and intimal-medial thickness (IMT) using Vascular Analysis Tools v. 5.5. All images were coded by number, blinded to group assignment, and analyzed by the same individual (K.L.M.). Time points that corresponded with maximal systolic expansion of the carotid artery and basal (minimum) diastolic relaxation were selected. Because the near-wall IMT cannot be precisely measured on a consistent basis, 12 diameter was measured as the distance between the vessel far-wall boundary, corresponding to the interface between the lumen and intima, and a near-wall boundary, corresponding to the interface between the media and adventitia. Note that this will tend to slightly overestimate the true absolute lumen diameter and influence the corresponding calculated wall stresses (see below). IMT was defined as the distance from the leading edge of the lumen-intima interface to the leading edge of the media-adventitia interface. 12 Wall thickness was normalized for lumen size and was expressed as IMT/lumen diameter ratio. Because arterial remodeling (ie, change in structural properties in response to atherogenic and/ or hemodynamic factors within the artery) is thought to be an adaptive response aimed at maintaining arterial wall stresses within certain limits to possibly preserve arterial compliance, circumferential wall stress was calculated. Circumferential tangential wall stress (dyn/cm 2 ), the tension that acts perpendicular to the arterial wall, was calculated using [(MBP Â D)/2]/IMT, where MBP is mean blood pressure (dyn/cm 2 ), D is diameter in centimeters, and IMT is expressed in centimeters. 13, 14 The intraobserver within-participant reliability for the measurement of carotid artery compliance was determined in nine participants studied on two different days at least 1 week apart. The coefficient of variation for the two trials was 4% T 2% for carotid artery compliance and 3% T 1% for carotid IMT.
Blood analyses
Fasting plasma concentrations of glucose, triglycerides, total cholesterol (Roche Diagnostic Systems) and high-density lipoprotein cholesterol (Diagnostic Chemicals, Ltd., Oxford CT) were determined using enzymatic/colorimetric methods, and low-density lipoprotein cholesterol was determined using the Friedewald equation. 15 Plasma or serum concentrations of estradiol and sex hormoneYbinding globulin (SHBG) were measured using conventional radioimmunoassay. The homeostasis model assessment (HOMA; fasting glucose Â fasting insulin/ 22.5) was used to calculate the insulin sensitivity index. 16 All assays were performed by the University of Colorado Denver Clinical Translational Research Centers core laboratory. Intraassay and interassay coefficients of variation were as follows: (1) glucose, 0.67% and 1.44%; (2) insulin, 5.2% and 9.8%; (3) triglyceride, 0.82% and 2.18%; (4) total cholesterol, 0.85% and 1.54%; (5) high-density lipoprotein cholesterol, 0.5% and 1.12%; (6) estradiol, 4.3% and 8.2%; and (7) SHBG, 3.6% and 5.7%, respectively.
Body composition and maximal oxygen consumption
Total fat mass and fat-free mass were determined using dual energy x-ray absorptiometry (DPX-IQ, Lunar Corp.). Minimal waist and hip circumferences were measured according to previously published guidelines, and waist-to-hip ratio (WHR) was calculated. 17 In a subset of women (no hysterectomy, n = 52; hysterectomy alone, n = 15; hysterectomy with BLO, n = 14), maximal oxygen consumption (VO 2max ), a measure of maximal aerobic exercise capacity, was determined using an incremental treadmill exercise protocol as described previously. 18 Statistical analysis W 2 tests were used to assess differences in categorical variables (eg, ethnicity and previous HT use) between women who did not have a hysterectomy, women who had hysterectomy alone, and women who had hysterectomy with BLO. One-way analysis of variance was used to assess group differences in continuous variables (ie, participant characteristics and hemodynamic/carotid artery structure) and arterial stiffness measurements. If significant differences were observed with analysis of variance, Scheffe post hoc analysis for multiple comparisons was performed to identify significant differences among the mean values. The skewness of postmenopause duration, estra-diol, triglycerides, and SHBG necessitated logarithmic transformation, and mean data presented have been reexponentiated with 95% CI. Exploratory analyses were performed using Pearson product correlations to test for the presence of significant linear bivariate relations between variables of interest.
To determine whether hysterectomy status was independently related to arterial stiffness, linear regression was performed where carotid artery compliance or A stiffness was entered as the dependent variable and hysterectomy alone and hysterectomy with BLO were entered as independent variables, with no hysterectomy being the reference group (model A). To ensure that any observed association between hysterectomy status and arterial stiffness was not confounded by age, menopause and HT duration, parity, CV risk factors, or sex hormone concentrations, we used a multiple regression model that included all of these factors that were significantly correlated with arterial stiffness (model B). AlthoughVO 2max was significantly associated with arterial compliance and A stiffness, it was excluded from model B because of limited sample size for this variable. SHBG was not a significant correlate of A stiffness in the population as a whole and was therefore not included in the regression model for A stiffness. Multicollinearity was controlled for by examining the correlations and associations between all independent variables included in the regression to detect a high level of association and by examining the tolerance and the variance inflation factor. Data are presented as 
RESULTS

Participant characteristics
Ethnicity, race, and past HT use were similar among groups ( Table 1 ). Time since menopause was longer and age at menopause was younger in women with hysterectomy with and without BLO compared with women with no hysterectomy (all P G 0.01, Table 1 ). Parity was greater and SHBG was lower in women with hysterectomy with ovarian preservation versus women with no hysterectomy (P e 0.05; Table 1 ). Duration of previous HT use was greater in women with hysterectomy and BLO compared with women with no hysterectomy (P G 0.01; Table 1 ). There were no group differences in body composition, blood pressure, estradiol, or fasting blood lipids, glucose, and insulin concentrations.
Arterial stiffness is greater in postmenopausal women with a history of hysterectomy Carotid artery compliance was 25% lower in women with hysterectomy with ovarian preservation and 20% lower in women with hysterectomy with BLO compared with women with no hysterectomy (both P G 0.05; Fig. 1 ). Qualitatively similar results were obtained when the data were expressed as A stiffness index, with the exception that there was no significant difference in A stiffness index between women with a history of no hysterectomy compared with those with a hysterectomy with BLO (P = 0.51). There were no differences in carotid artery compliance (P = 0.59) or A stiffness index (P = 0.37) between women with hysterectomy with ovarian preservation and those with hysterectomy with BLO. Table 2 presents the peripheral hemodynamic and carotid artery structure data. Carotid lumen diameter and interadventitial diameter were smaller in women with hysterectomy with BLO compared with women with no hysterectomy (both P G 0.01) but were not different between women with hysterectomy with ovarian preservation and women with no hysterectomy. Carotid artery distention was lower in women with hysterectomy alone (P G 0.01) and tended to be lower in women with hysterectomy with BLO (P = 0.08) compared with women with no hysterectomy. There were no differences in carotid diameter, interadventitial diameter, and distention between women with hysterectomy alone compared with those with BLO. There also were no differences in IMT, IMT/diameter ratio, peripheral blood pressure, or tangential wall stress between any of the groups (all P 9 0.70).
In the overall population, carotid artery compliance was inversely related to age (r = j0.45), parity (r = j0.37), postmenopause duration (r = j0.28), WHR (r = j0.27), and seated systolic blood pressure (r = j0.31) and positively related to SHBG (r = 0.25) andVO 2max (r = 0.26; all P G 0.05). A stiffness index showed the same general relations but was not significantly correlated with SHBG. Among postmenopausal women with hysterectomy with and without BLO, carotid artery compliance was inversely related to age (r = j0.43), postmenopause duration (r = j0.30), parity (r = j0.41), WHR (r = j0.37), and seated systolic (r = j0.42) and diastolic (r = j0.34) blood pressure and positively related to SHBG (r = 0.31; all P G 0.05). A stiffness index showed a positive correlation with age (r = 0.46), parity (r = 0.30), and seated systolic blood pressure (r = 0.34; all P G 0.05).
Regression analysis confirmed the above results that hysterectomy status is a significant predictor of arterial stiffness. Initial crude analysis (model A) showed that hysterectomy alone (A = j0.33, P = 0.001) and hysterectomy with BLO (A = j0.25, P = 0.01) were significant predictors of arterial compliance. Hysterectomy alone was a significant predictor of A stiffness index (A = 0.29, P = 0.004) but not hysterectomy with BLO (A = 0.14, P = 0.15). After adjustment for age, postmenopause duration, past HT duration, parity, WHR, systolic blood pressure, and SHBG (model B), the results were qualitatively similar. In model B, in addition to hysterectomy alone (A = j0.24, P = 0.02) and hysterectomy with BLO (A = j0.23, P = 0.03), age (A = j0.32, P = 0.003) was also a significant predictor of arterial compliance, and for A stiffness index, only hysterectomy alone (A = 0.25, P = 0.02) and age (A = 0.31, P = 0.009) were significant predictors. Figure 2 demonstrates the decline in arterial compliance at a given age for women with hysterectomy with/without BLO and no hysterectomy.
DISCUSSION
The novel finding of this study is that healthy postmenopausal women with a history of a hysterectomy have stiffer large elastic arteries compared with postmenopausal women with no history of hysterectomy. The greater arterial stiffness is evident in both women with BLO and in those with ovarian preservation with hysterectomy. In addition, the greater arterial stiffness in women with a history of hysterectomy does not seem to be associated with an adverse arterial remodeling, nor is it related to an adverse CVD risk factor profile.
Hysterectomy with ovarian preservation and with BLO is associated with a greater degree of coronary atherosclerosis, calcified plaque, and increased CVD events. 2, 3, 5, 19 The mechanisms underlying these associations have not been fully elucidated, although recent data from the WHI Observational Study attribute the increased CVD risk with hysterectomy to an adverse CVD risk factor profile. 3 However, our results demonstrating that women with hysterectomy with or with-out BLO have greater arterial stiffening (ie, reduced arterial compliance) compared with age-matched women with no hysterectomy provides evidence for a possible biological effect of hysterectomy per se on arterial health. First, in contrast to previous observational studies, 2, 3, 5 we included only women who were normotensive, nonsmokers, nondiabetic, and not taking CV or lipid-lowering medications, thus removing some potential influence of overt disease and medication status on the vascular wall. Second, there were no differences in carotid IMT, blood pressure, adiposity, blood lipid profile, glucose, insulin, or maximal aerobic capacity between our groups, indicating that women with hysterectomy with or without BLO did not have a worse CVD risk profile. Finally, hysterectomy status remained a significant predictor of carotid artery compliance after adjustment for CVD risk factors (ie, WHR and blood pressure) that were correlated with arterial compliance. As such, our data indicate that the greater arterial stiffening observed in women with hysterectomy with or without BLO is not related to an adverse CVD risk profile but rather, possibly, to an independent biological effect of hysterectomy on the arterial wall. Because arterial stiffness, a biomarker of vascular aging, is an independent predictor of CVD and all-cause mortality, 7 our findings suggest that the increased CVD risk with hysterectomy may be mediated via an acceleration in vascular aging.
The mechanisms by which hysterectomy increases arterial stiffness in women are unclear. Women who have a history of hysterectomy have been reported to have greater parity, which is associated with increased CVD risk. 20, 21 Pregnancy is associated with insulin resistance, lipid abnormalities, inflammation, and impaired endothelial function. 21, 22 As such, the increased CVD risk has been attributed to accumulated damage from these factors with successive pregnancies. In the present study, parity was higher in women with hysterectomy alone compared with women with no hysterectomy and was inversely correlated with carotid artery compliance. However, after adjusting for parity, hysterectomy remained a significant predictor of carotid artery compliance, indicating that the greater arterial stiffness in women with hysterectomy was not related to the potential metabolic or inflammatory adverse effects associated with a greater number of pregnancies.
In the present study, serum SHBG concentrations were lower in postmenopausal women with a history of hysterectomy with ovarian preservation compared with women who did not have a hysterectomy. Low SHBG has been reported to be associated with increased coronary atherosclerosis and CVD events. 23 The link between low SHBG and CVD risk has been attributed to hyperandrogenism, as well as an adverse metabolic profile (ie, elevated glucose, insulin, low-density lipoprotein cholesterol, and central adiposity) and inflammation. 24, 25 Consistent with this, in the present study, SHBG concentrations were strongly correlated with WHR (r = j0.53) and insulin (r = j0.51) in women with hysterectomy with or without oophorectomy. Moreover, SHBG was positively correlated with carotid artery compliance in the overall population and in women with hysterectomy but not in women with no hysterectomy, suggesting that low SHBG concentrations may be a mechanism contributing to the greater arterial stiffening in women with hysterectomy. However, including SHBG in the regression analyses did not eliminate the effect of hysterectomy on arterial stiffness in our population.
In women, the age-associated increase in arterial stiffness seems to be augmented around the menopausal transition, presumably related to estrogen deficiency. 8<10 As such, premature menopause and the resulting estrogen deficiency may be a potential mechanism for the apparent acceleration in large artery stiffening with hysterectomy. Estrogen has been shown to influence factors that contribute to arterial stiffness, including the structural composition within the arterial wall (ie, increased elastin and decreased collagen and IMT) and the contractile state of vascular smooth muscle cells (ie, increased nitric oxide bioavailability). 14, 26, 27 In the WHI Coronary Artery Calcium substudy, women who had any oophorectomy and no prior HT use had higher odds of subclinical atherosclerosis compared with women who had any oophorectomy and were prior HT users. 5 In addition, among women with BLO, HT use within 5 years of oophorectomy was associated with a lower prevalence of subclinical atherosclerosis. 5 Similarly, in the Nurses' Health Study, undergoing BLO before the age of 50 years was associated with an increased risk of all-cause mortality, coronary heart disease, and stroke in those women who had never used HT. 28 In the present study, women with hysterectomy with or without BLO had used HT longer than had women with no hysterectomy. However, when past HT duration was controlled for in the regression model, hysterectomy remained a significant predictor of carotid artery compliance. This finding may be explained by the fact that there was no difference in the time since past HT use between the groups, and thus, the overall duration of estrogen deficiency was similar. Alternatively, it is possible that we were unable to detect the protective effect of past HT initiated within 5 years of menopause on arterial stiffness because of our small sample size and/or our inability to quantify the timing of HT initiation with the onset of menopause.
We found that the influence of hysterectomy on arterial stiffening was similar between women with BLO and those with ovarian preservation, consistent with observational studies reporting an increased risk for CVD in women with hysterectomy alone. 2, 3 Women with hysterectomy with ovarian preservation have been reported to have higher follicle-stimulating hormone concentrations and an earlier menopause (45 T 4 y) compared with women with no hysterectomy (50 T 4 y). 4, 29 Earlier menopause has been attributed to premature ovarian failure related to a disruption in ovarian blood flow with hysterectomy. 2 Furthermore, women with a hysterectomy with ovarian preservation are less likely to be treated with HT than are women who have BLO and are thus more likely to have an untreated relative estrogen deficiency. 5 
Considerations and experimental limitations
Even though carotid artery compliance was significantly reduced in women with hysterectomy regardless of oopho-rectomy status, this was not the case for A stiffness index, which was significantly elevated only in women with hysterectomy with ovarian preservation. Thus, a potential limitation to the study could be the small sample sizes in the hysterectomy groups compared with the no hysterectomy group. A stiffness index adjusts arterial compliance for distending pressures, which were similar among the groups. Thus, it is possible that if we had larger sample sizes in these groups, hysterectomy with BLO would have been associated with a greater A stiffness index. In addition, because carotid artery diameter was smaller in women with hysterectomy with BLO, it is possible that their reduced carotid artery compliance was related to an adverse arterial remodeling. Arterial remodeling (ie, alterations in artery structural characteristics in response to atherogenic and/or hemodynamic forces) is thought to be an adaptive response to maintain circumferential wall and shear stresses within the artery to possibly preserve compliance. Arterial remodeling is typically characterized by increases in IMT and diameter (outward remodeling), although it has been observed in the early stages of atherosclerosis that coronary arteries enlarge in relation to plaque area to preserve the lumen until the plaque area occupies 40% or more of vessel area. 30 However, in the present study, the smaller carotid diameter in the hysterectomy with BLO women corresponded to a smaller carotid IMT and not a larger IMT. Moreover, there was no difference among the groups in IMT/lumen ratio or circumferential (tangential) wall stress, nor was IMT or wall stress correlated with measures of arterial stiffness. Thus, based on the available data that we have to assess arterial remodeling, it does not appear that the reduced arterial compliance in the women with hysterectomy with/without BLO is associated with a particular pattern of adaptive remodeling. These data are consistent with our previous studies demonstrating no differences in carotid IMT between age-matched sedentary and endurance-trained older adults despite the endurance-trained older adults having a significantly greater carotid artery compliance. 9, 11, 31 In addition, arterial stiffness has been reported to be similar between middle-aged adults with greater IMT and those with smaller IMT. 32 One potential explanation for this phenomenon may be related to the inclusion of healthy participants in the present study (normotensive, nondiabetic, no signs or symptoms of overt CVD).
We recognize that because our study was cross-sectional, we cannot prove causality, and thus, our findings must be interpreted with caution. We relied on self-report measures of menopause, hysterectomy, HT use, and duration of HT use, and thus, it is possible that this information and the classification of groups were inaccurate. We also cannot rule out other constitutional or genetic factors that could be influencing arterial stiffening in women with hysterectomy with or without BLO. For example, low socioeconomic status and physical activity levels are associated with hysterectomy and increased CVD risk. 20, 33 Thus, it is possible that women with surgical menopause had lower socioeconomic status and physical activity levels. To the extent possible, we eliminated constitutional factors by matching the menopausal groups for age, CVD risk factors, and aerobic capacity (VO 2max ) and adjusted our analysis for parity and past HT use. AlthoughVO 2max may not be representative of total daily physical activity, it does reflect overall aerobic fitness and has been shown by numerous studies to provide a strong, independent graded inverse association with CVD and all-cause mortality in healthy and unhealthy populations. 34 Moreover, we and others have previously shown that maximal aerobic capacity is correlated with arterial stiffness in healthy older adults. 9, 11, 31, 35 In addition, because we studied only healthy nonsmoking, normotensive, sedentary postmenopausal women without evidence of overt chronic diseases, our findings can be generalized only to this population of women.
Clinical significance
Hysterectomy is the second most common surgical procedure in women in the United States behind cesarean section, with È600,000 women undergoing hysterectomies a year. 6 As such, understanding the physiological changes that accompany gynecological surgical procedures is important when evaluating current standard of care and future health risk analysis. CVD is a public health concern in women, 36 and the results of the present study provide new insight into the possible pathophysiological role of hysterectomy with or without BLO on CVD risk in healthy women. Specifically, our findings demonstrate that healthy women with hysterectomy have accelerated vascular aging compared with women with natural menopause independent of CVD risk factors. Vascular aging is a major risk factor for the development of CVD, and accelerated or early vascular aging may manifest into early CVD events. 37 Because hormonal dysregulation may contribute to the initiation and progression of CVD, 38,39 a better understanding is needed of the effects of hysterectomy, premature menopause, and the onset of hypoestrogenemia on the mechanisms initiating vascular aging.
CONCLUSIONS
In conclusion, our results demonstrate that a history of hysterectomy in women (regardless of oophorectomy status) is associated with greater arterial stiffening when compared with women of the same age without a history of hysterectomy. The greater arterial stiffening with hysterectomy is not related to an adverse CVD risk profile. Large artery stiffening may be an important mechanism by which hysterectomy increases the risk of CVD in postmenopausal women.
